Elevation of the Plasma A beta(40)/A beta(42) Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF ALZHEIMERS DISEASE48(4) · pp.1043 · 2015
- 피인용
- Web of Science 37
- JCR IF
- JCR 2014 4.151
- ISSN
- 1387-2877
저자
- Kim, Hyeong Jun제1저자Department of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Park, Kyung WonDepartment of Neurology, Dong-A University College of Medicine, Dong-A University Hospital, Busan, South Korea
- Kim, Tae EunDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Im, Ji YoungDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Shin, Ho SikDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Kim, SaeromiDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Lee, Dong HyunDepartment of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
- Ye, Byoung SeokDepartment of Neurology, Yonsei University, College of Medicine, Seoul, South Korea
- Kim, Jong HunDepartment of Neurology, Ilsan Hospital, National Health Insurance Corporation, Goyang, South Korea
- 김은주Department of Neurology, Pusan National University Hospital, Busan, South Korea
- Park, Kee HyungDepartment of Neurology, Gachon University, College of Medicine, Incheon, South Korea
- Han, Hyun JeongDepartment of Neurology, Myongii Hospital, Seonam University, Goyang, South Korea
- Jeong, Jee HyangDepartment of Neurology, Ewha Womans University, Mokdong Hospital, Seoul, South Korea
- Choi, Seong HyeDepartment of Neurology, Inha University, School of Medicine, Incheon, South Korea
- Park, Sun Ah교신저자Department of Neurology, Soonchunhyang University, Bucheon Hospital, Bucheon, South Korea
초록
Background: Although plasma amyloid-beta (A beta) levels have been evaluated as a possible diagnostic marker of Alzheimer's disease (AD), the findings are inconsistent. Objective: The present study aimed to validate plasma levels of A beta(40), A beta(42), and the A beta(40)/A beta(42) ratio as biomarkers of AD in subjects with early-onset AD (EOAD) without familial AD genetic mutations. Methods: Patients with sporadic EOAD (sEOAD) were prospectively recruited by nine neurology clinics. Plasma levels of A beta(40) and A beta(42) were measured using a sandwich enzyme-linked immunosorbent assay (ELISA) in 100 sEOAD (50-69 year-old) and 46 age-matched normal control subjects (50-72 year-old). Cerebrospinal fluid (CSF) was obtained from 32 sEOAD subjects and 25 controls. The integrity of the blood-brain barrier was assessed using the CSF/plasma albumin ratio. Results: The plasma levels of A beta(42) were significantly lower, while the A beta(40)/A beta(42) ratio was significantly higher in sEOAD patients than in controls. The levels of A beta(40), A beta(42), and the A beta(40)/A beta(42) ratio did not differ in relation to the APOE epsilon 4 allele. The CSF/plasma albumin ratio was comparable between the two groups, and the plasma parameters of A beta proteins were not significantly associated. A multivariate analysis revealed that an increased A beta(40)/A beta(42) ratio is valuable for the discrimination of sEOAD from controls (beta = 0.344, p = 0.000). The area under the ROC curve for the A beta(40)/A beta(42) ratio was 0.76, and a cut-off ratio of 5.87 was suggested to have 70% sensitivity and 68% specificity. Conclusion: The plasma A beta(40)/A beta(42) ratio had moderate validity for the discrimination of sEOAD patients from age-matched controls.
키워드
Alzheimer's diseaseamyloid-beta proteinbiomarkerblood-brain barrierplasmaBLOOD-BRAIN-BARRIERMILD COGNITIVE IMPAIRMENTAMYLOID-BETA LEVELSCEREBROSPINAL-FLUIDRISKASSOCIATIONBIOMARKERSDEMENTIAPEPTIDEDECLINE
식별자
- WoS UID
- 000363867300016



로그인
연구물 목록으로